TVTX

Travere Therapeutics
TVTX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.78B
EV
$1.81B
Shares Outstanding
88.77M
Beta
0.84

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$33.67
P/E 2025E
-
P/Revenue 2025E
4.62x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Travere Therapeutics, Inc.

gainify
TVTX

Travere Therapeutics, Inc.

TVTX

Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases. Its products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pa...

Sector

Healthcare

Industry

Biotechnology

CEO

Dube, Eric

Employees

385

IPO Date

2012-11-08

Headquarters

3611 Valley Centre Drive, Suite 300, San Diego, California, 92130, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved